HIg

[Composition]
Active ingredients: human hepatitis B immunoglobulin
Excipients: glucose, Polysorbate 80, NaCl, glycine, WFI
[Characters]
It is a colorless or light yellow clear liquid, with opalescence but without turbidity. [Indications]
The product is mainly used to prevent hepatitis B, and indicated for:
1. Newborns whose mothers are HBsAg positive.
2. People with accidental infection
3. Close contacts with hepatitis B patients or hepatitis B virus carriers.
[Administration and Dosage]
Administration: The product is for intramuscular injection exclusively; intravenous infusion is
contraindicated.
Dosage: 1. Prevention of Mother to Child Transmission (PMTCT): Newborns whose mothers are
HBsAg positive should receive 100 IU of the product within 24 hours after birth. The dosage and
timing of administration of hepatitis B vaccine please refer to the package insert or the direction of
the physician.
2. Prevention from hepatitis B: each single human dose of 100 IU for children and 200 IU for
adults; a repeated dose is injected at an interval of 3～4 weeks if necessary.
3. Accidental infection: inject 8～10IU/kg BW as soon as possible (at latest not more than 7 days);
inject one more dose after one month.
[Adverse Reactions]
Generally no adverse reactions occur after injection. Redness and swelling or pain in the site of
injection may appear in a few people. Normally no treatment is necessary, for it could be recover
by itself.